Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02985658
Title Expanded Access With ABT-888 (Veliparib) to Treat Metastatic Breast Cancer
Recruitment Available
Gender female
Phase Phase I
Variant Requirements No
Sponsors University of Washington
Indications

triple-receptor negative breast cancer

breast cancer

Therapies

Cisplatin

Veliparib

Vinorelbine

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.